IP Library Patent Application 17727630
Patent Application
App. No. 17/727,630

NITRIC OXIDE GENERATION, DILUTION, AND TOPICAL APPLICATION COMPOSITIONS, SYSTEMS, APPARATUS AND METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/727,630
Abstract

An apparatus for controlled delivery of nitric oxide. A pump draws air through an activated carbon filter and into a reaction chamber. The generation of nitric oxide occurs in the reaction chamber. A second pump draws the gas in the reaction chamber through a calcium hydroxide filter and delivers the nitric oxide through an orifice, or aperture, that controls the flow of nitric oxide delivered. The nitric oxide is filtered through a calcium hydroxide filter just prior to being made available for various nitric oxide therapies. Topical applications that provide a nitric oxide therapy to a surface are also provided.

Claims (25)

1 .- 14 . (canceled)

15 . A method for providing a topical nitric oxide therapy system, comprising:

providing a nitrite medium in a first container, the nitrite medium comprising about 95% water by weight, about 3% of a nitrite component by weight, greater than about 1% hydroxypropyl methylcellulose polymers by weight, and less than about 1% by weight of a combination of additives comprising two or more of methylchloroisothiazolinone, methylisothiazolinone, sodium hydroxide, ethylenediamine tetraacetate tetrasodium salt, and citric acid;

providing an acidic medium in a second container, the acidic medium comprising about 89% water by weight, about 9% by weight of a combination of two or more acidic reactants; greater than about 1% hydroxypropyl methylcellulose polymers by weight, and less than about 1% by weight of a combination of additives comprising two or more of methylchloroisothiazolinone, methylisothiazolinone, sodium hydroxide, and ethylenediamine tetraacetate tetrasodium salt;

combining the nitrite medium and the acidic medium to form a nitric oxide topical medium producing nitric oxide suitable for topical application and suitable for administering nitric oxide therapy; and

applying a therapeutically effective amount of the nitric oxide topical medium to a treatment surface suitable for receiving nitric oxide therapy, whereby the application of the therapeutically effective amount is adapted to deliver a dose of nitric oxide at the treatment surface of a patient.

16 . The method of claim 15 , wherein the water comprises one or more of distilled water and deionized water.

17 . The method of claim 15 , wherein the nitrite component comprises one or more nitrite reactants of sodium nitrite and potassium nitrite.

18 . The method of claim 15 , wherein the combination of the acidic reactants comprises about 3% lactic acid by weight, about 3% ascorbic acid by weight, and about 3% citric acid by weight.

19 . The method of claim 15 , wherein one or more of the first and second containers comprise a pump configured to dispense a medium by a pump action.

20 . The method of claim 15 , wherein the therapeutically effective amount of the topical medium is configured to produce nitric oxide gas having a concentration of between about 500 ppm and about 1000 ppm.

21 . The method of claim 15 , wherein the therapeutically effective amount of the topical medium is configured to produce nitric oxide gas having a concentration of between about 1000 ppm and about 2000 ppm.

22 . The method of claim 15 , wherein the treatment surface is the skin of a patient.

23 . The method of claim 15 , wherein the topical medium is repeatedly applied to an open wound once a day for at least one week.

24 . The method of claim 15 , wherein the topical medium is repeatedly applied to an open wound once a day for up to three weeks.

25 . The method of claim 15 , wherein the topical medium is repeatedly applied to an open wound for up to five weeks.

26 . The method of claim 15 , wherein the dose of nitric oxide provides an antimicrobial treatment to the patient.

27 . The method of claim 15 , wherein the dose of nitric oxide provides an antifungal treatment to the patient.

28 . The method of claim 15 , wherein the dose of nitric oxide provides an antiviral treatment to the patient.

29 . The method of claim 15 , wherein the dose of nitric oxide provides an antibacterial treatment to the patient.

30 . The method of claim 15 , wherein the dose of nitric oxide provides an antiseptic treatment to the patient.

31 . The method of claim 15 , wherein the dose of nitric oxide provides an analgesic treatment to the patient.

32 . The method of claim 15 , wherein the dose of nitric oxide provides an anti-inflammatory treatment to the patient.

33 . The method of claim 15 , wherein the dose of nitric oxide provides a biofilm-dispersion treatment to the patient.

34 . The method of claim 15 , wherein the dose of nitric oxide provides an anti-cancer treatment to the patient.

Assignments (6)
SECURITY INTEREST Recorded Apr 24, 2024
From: NO2020, LLC
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 067217/0866 →
SECURITY INTEREST Recorded Apr 24, 2024
From: SYK TECHNOLOGIES LLC
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 067217/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2022
From: MILLER, J.W. RANDOLPH; MILLER, JOHN J.; FAIRBANKS, STEPHEN H.
To: GENOSYS, INC.
Reel/Frame 061258/0955 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2022
From: GENOSYS
To: PATE BAIRD, PLLC
Reel/Frame 061259/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2022
From: PATE BAIRD, PLLC
To: KIMBALL, SY
Reel/Frame 061259/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2022
From: KIMBALL, SY
To: SYK TECHNOLOGIES, LLC
Reel/Frame 061259/0047 →